EPO:Fc (Syntonix)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameEPO:Fc (Syntonix)

Drug Alias Nameerythropoetin:Fc fusion (Syntonix)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionErythropoietin receptor agonists

TargetsErythropoietin receptor

Therapy Area/IndicationsAnemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBioverativ Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBioverativ Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsAnemia

Other Information

ATC CodeN/A